B6.129-Anpeptm1Afk/AfkH

Status

Available to order

EMMA IDEM:09063
Citation informationRRID:IMSR_EM:09063 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129-Anpeptm1Afk/AfkH
Alternative nameAnpep
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolAnpeptm1Afk
Gene/Transgene symbolAnpep

Information from provider

ProviderAndreas Kolb
Provider affiliationUniversity of Aberdeen
Genetic informationThe strain carries a partial deletion of the aminopeptidase N (Anpep) gene which deletes exons 2 through 9. This part of the protein contains the catalytic centre and a region identified as being involved in the binding of group 1 coronaviruses.
Phenotypic informationHomozygous:
No overt phenotype is detected in the homozygous Anpep knock-out mice. A delay in mammary development was detected. Similar knock-outs for Anpep have shown a deficiency in tumour vascularisation. This was not assessed for this mutated allele.

Heterozygous:
Heterozygous mice have no detectable phenotype.
Breeding historyMice were generated by Genoway by targeting in 129Sv ES cells and transfer of the modified cells into C57BL/6J hosts. These were bred onto C57BL/6J background and founder mice carrying the modified allele were received from Genoway.
References
  • Mammary gland development is delayed in mice deficient for aminopeptidase N.;Kolb Andreas F, Sorrell David, Lassnig Caroline, Lillico Simon, Carlisle Ailsa, Neil Claire, Robinson Claire, Müller Mathias, Whitelaw C Bruce A, ;2013;Transgenic research;22;425-34; 22983824
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal cornea morphology / IMPC
  • increased cardiac muscle contractility / IMPC
  • corneal deposits / IMPC
MGI phenotypes (allele matching)
  • impaired mammary gland growth during pregnancy / MGI
MGI phenotypes (gene matching)
  • abnormal macrophage physiology / MGI
  • pathological neovascularization / MGI
  • immune system phenotype / MGI
  • reproductive system phenotype / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • retinal neovascularization / MGI
  • impaired mammary gland growth during pregnancy / MGI

Literature references

  • Mammary gland development is delayed in mice deficient for aminopeptidase N.;Kolb Andreas F, Sorrell David, Lassnig Caroline, Lillico Simon, Carlisle Ailsa, Neil Claire, Robinson Claire, Müller Mathias, Whitelaw C Bruce A, ;2013;Transgenic research;22;425-34; 22983824

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).